Simple preparation and purification of ethanol-free solutions of 3'-deoxy-3'-[ 18F]fluorothymidine by means of disposable solid-phase extraction cartridges

Nuclear Medicine and Biology

Volumn 39, Issue 4, 2012, Pages 540-550

  Pascali, Claudio ^a   Bogni, Anna ^a   Fugazza, Lorenza ^b   Cucchi, Claudio ^a   Crispu, Ornella ^c   Laera, Luca ^a   Iwata, Ren ^d   Maiocchi, Greta ^a   Crippa, Flavio ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Advanced Accelerator Applications   (Italy)

^c Dani Instrument Spa   (Italy)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

18F FLT; Automation; Fluorothymidine; PET tracer; SPE cartridge purification

Indexed keywords

3' FLUOROTHYMIDINE F 18; ALCOHOL;

ARTICLE; AUTOMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SYNTHESIS; ENERGY YIELD; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; NUCLEOPHILICITY; ONE POT SYNTHESIS; PURIFICATION; RADIOLYSIS; REACTION OPTIMIZATION; RELIABILITY; SOLID PHASE EXTRACTION;

DIDEOXYNUCLEOSIDES; DISPOSABLE EQUIPMENT; ETHANOL; HUMANS; SAFETY; SOLID PHASE EXTRACTION; SOLUTIONS;

EID: 84860341315     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.10.005     Document Type: Article

References (48)

1. Shreve P.D., Anzai Y., Wahl R.I. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:61-77.
2. Pio B.S., Park C.K., Pietras R., Hsueh W.A., Satyamurthy N., Pegram M.D., et al. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol 2006, 8:36-42.
3. 3H]- thymidine, and gallium-67. J Nucl Med 1991, 32:2118-2123.
4. Vander Borght T., Pauwels S., Lambotte L., Labar D., De Maeght S., Stroobandt G., et al. Brain tumour imaging with PET and 2-[carbon-11]thymidine. J Nucl Med 1994, 35:974-982.
5. 11C]Thymidine and FDG to measure therapy response. J Nucl Med 1998, 39:1757-1762.
6. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.J., Stayanoff J.C., Lawhorn Crews J.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998, 4:1334-1336.
7. 18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004, 31:1659-1672.
8. Rasey J.S., Grierson J.R., Wiens L.W., kolb P.D., Schwartz J.L. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 2002, 43:1210-1217.
9. Sherley J.L., Kelly T.J. Regulation of thymidine kinase during the cell cycle. J Biol Chem 1988, 263:8350-8358.
10. 18F]FLT: portrait of a proliferation marker. Eur J Nucl Med Mol Imaging 2002, 29:165-169.
11. Kong X.B., Zhu Q.Y., Vidal P.M., Watanabe K.A., Polsky B., Armstrong D., et al. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Antimicrob. Agents Chemother 1992, 36:808-818.
12. 76Br-BFU as proliferation markers. J Nucl Med 2002, 43:1688-1698.
13. 18F-FDG. J Nucl Med 2003, 44:1426-1431.
14. 18F- radiolabeling, as a tracer for the non-invasive monitoring of the biodistribution of drugs against AIDS. J Fluor Chem 1991, 55:283-289.
15. 18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol 2000, 27:143-156.
16. 18F]FLT). J Radioanal Nucl Chem 2000, 243:843-846.
17. 18F]FLT. Nucl Med Biol 2002, 29:263-273.
18. 18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent. Eur J Nucl Med Mol Imaging 2007, 34:1406-1409.
19. 18F]fluorothymidine. Nucl Med Biol 2004, 31:803-809.
20. 18F]fluorothymidine. Appl Radiat Isot 2010, 68:1734-1739.
21. 18F]fluorothymidine using (5'-O-dimethoxytrityl)-2'-deoxy-3'-O-nosyl-β-d-threo-pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor. Nucl Med Biol 2003, 30:151-157.
22. 18F]fluorothymidine using three precursors. Appl Radiat Isot 2006, 64:187-193.
23. 18F]fluoro-l-thym idine with simplified purification using a combination-column. J Labelled Compd Radiopharm 2007, 50:S121.
24. 18F]FLT. J Radional Nucl Chem 2010, 283:245-251.
25. 18F]-3'-deoxy-3'-fluorothymidine using anhydro precursor and single neutral alumina column purification. J Radioanal Nucl Chem 2010, 283:741-748.
26. Walsh JC, Padgett HC, Ysaguirre T. Method for preparing radiolabeled thymidine having low chromophoric byproducts. 2005, PCT WO 2005/058247 A2.
27. Trump DP. Radiolabeled thymidine solid-phase extraction purification method. 2005, PCT WO 2005/025519 A2.
28. Husbyn M. Separation process. 2010, US 2010/0105888 A1.
29. Tadino V, Muller M. Process for synthesizing labeled compounds. 2006, PCT WO 2006/133732 A1.
30. Pascali C, Bogni A. Purification procedure for the preparation of the radioactive tracer 3'deoxy-3'-[18F]fluorothymidine ([18F]FLT). 2008, WO 2008/146316 A1.
31. 18F]FDG preparations. Nucl Med Biol 1997, 24:193-195.
32. 18F]2-fluoro-2-deoxy-d-glucose. Nucl Med Biol 1989, 16:385-387.
33. 18F]FDG synthesis by Anatech RB-86 robotic system: improvements and general considerations. J Radioanal Nucl Chem 1998, 230:45-50.
34. European Pharmacopoeia 6th edition, Residual Solvents 2008, 603-610. Strasbourg, France.
35. Kim D.W., Ahn D.S., Oh Y.H., Lee S., Kil H.S., Oh S.J., et al. A new class of SN2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules. J Am Chem Soc 2006, 128:16394-16397.
36. 18F]fluorothymidine by nucleophilic fluorination in various alcohol solvents. J Labelled Compd Radiopharm 2008, 51:80-82.
37. 18F]FLT) in ionic liquid, [bmim][OTf]. J Labelled Compd Radiopharm 2006, 49:287-293.
38. 18F]FLT: syntheses and radiofluorination trials. Nucl Med Biol 2008, 35:413-423.
39. 18F]fluorothymidine as a new marker for monitoring tumour response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 2003, 63:3791-3798.
40. 18F]FLT. Appl Radiat Isot 2007, 65:1350-1358.
41. 18F]-FLT) for positron emission tomography imaging. J Pharm Biomed Anal 2007, 45:154-157.
42. 3. Appl Radiat Isot 1995, 46:887-891.
43. 18F]2-deoxy-2-fluoro-d-glucose: a paradigm in the routine synthesis of fluorine-18 radiopharmaceuticals. Nucl Med Biol 1989, 16:533-551.
44. 18F]FLT) and the fate of the precursor 2,3'-anhydro-5'-O-(4,4'-dimethoxytrityl)-thymidine. J Labelled Compd Radiopharm 2001, 44:S871-S873.
45. Kaul S., Dandekar K.A., Schilling B.E., Barbhaiya R. Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T). Drug Metab Dispos 1999, 27:1-12.
46. Shi J., Ray A.S., Mathew J.S., Anderson K.S., Chu C.K., Schinazi R.F. 2',3'-Didehydro-2',3'-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditions. Biorg Med Chem Lett 2004, 14:2159-2162.
47. Krishnan T.A., Chanda M. Kinetics of polymerization of furfuryl alcohol in aqueous solution. Angew Makromol Chem 1975, 43:145-156.
48. Batista P.S., Ferreira de Souza M. Furfuryl polymerization inside capillaries. Synth Met 1999, 101:635-636.